Trials / Completed
CompletedNCT05401721
Serum Copeptin in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 89 (actual)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Current reports have demonstrated that copeptin predicts disease progression and prognosis in cirrhotic patients, independent of liver-specific scoring systems. To the best of our knowledge, few studies have addressed the association between copeptin and sepsis in cirrhotic patients, however, they were performed on different types of infections. Therefore, we will conduct this study with a focus on it is possible role in patients with SBP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Serum copeptin | Blood test |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2022-06-02
- Last updated
- 2022-06-02
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05401721. Inclusion in this directory is not an endorsement.